9 active trials 3 recruiting 7 sponsors 3 changes in 30 days
| Phase 1 | 3 | |
| Phase 3 | 1 |
| NCT ID | Title | Sponsor | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06244628 | Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD | Xuzhou Medical University | Recruiting | 2026-05-27 |
| Phase 1 | ||||
| NCT07127926 | Evaluation of Belumosudil Whole Tablets vs. Crushed Tablets Pharmacokinetics in Patients… | M.D. Anderson Cancer Center | Recruiting | 2026-08-27 |
| NCT06991361 | Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory… | Leslie Kean | Recruiting | 2026-07-23 |
| NCT01937468 | Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic… | Dana-Farber Cancer Institute | Active, Not Recruiting | 2026-02-05 |
| Not applicable | ||||
| NCT06458127 | Tele-Palliative Care Intervention for Patients With Chronic Graft-Versus-Host Disease | Massachusetts General Hospital | Active, Not Recruiting | 2026-04-06 |
| NCT04479995 | Multidisciplinary Intervention In Chronic GVHD | Massachusetts General Hospital | Active, Not Recruiting | 2026-01-20 |
| Not specified | ||||
| NCT00637689 | Improving Outcomes Assessment in Chronic GVHD | Fred Hutchinson Cancer Center | Active, Not Recruiting | 2026-04-20 |
| NCT01902576 | Chronic GVHD Response Measures Validation | Fred Hutchinson Cancer Center | Active, Not Recruiting | 2026-03-20 |
| NCT02611180 | Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease | Washington University School of Medicine | Active, Not Recruiting | 2026-03-16 |
Fred Hutchinson Cancer Center (2) · Massachusetts General Hospital (2) · Dana-Farber Cancer Institute (1) · Leslie Kean (1) · M.D. Anderson Cancer Center (1) · Washington University School of Medicine (1) · Xuzhou Medical University (1)